1,731
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Ultrasound-guided percutaneous microwave ablation assisted by athree-dimensional visualization treatment platform combined with transcatheter arterial chemoembolization for a single large hepatocellular carcinoma 5 cm or larger: a preliminary clinical application

, ORCID Icon, , , , , , & show all
Pages 44-54 | Received 05 Oct 2017, Accepted 25 Sep 2018, Published online: 25 Oct 2018

References

  • El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–1127.
  • Zuo TT, Zheng RS, Zhang SW, et al. Incidence and mortality of liver cancer in China in 2011. Chin J Cancer. 2015;34:508–513.
  • Tang A, Hallouch O, Chernyak V, et al. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY). 2018;43:13–25.
  • Liu X, Wang Z, Chen Z, et al. Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: a systematic review and meta-analysis. Oncol Res. 2017;26:231.
  • Wang YM, Qian GJ, Xu Y, et al. Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases. Zhonghua Gan Zang Bing Za Zhi. 2017;25:344–348.
  • Lucchina N, Tsetis D, Ierardi AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol. 2016;29:460–465.
  • Sacco R, Tapete G, Simonetti N, et al. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review. Jhc. 2017;4:105–110.
  • Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2012;61:1100–1101.
  • Liang P, Yu J, Lu MD, et al. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. Wjg. 2013;19:5430–5438.
  • Oliveri RS, Wetterslev J, Gluud C. Hepatocellular carcinoma. Lancet. 2012;380:470.
  • Lin YH, Chiou YY, Chou YH, et al. Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysis. Eur J Gastroenterol Hepatol. 2011;23:1239–1244.
  • Ke S, Gao J, Kong J, et al. Repeated radiofrequency ablation combined with ablated lesion elimination and transarterial chemoembolization improves the outcome of solitary huge hepatocellular carcinomas 10 m or larger. Medicine (Baltimore). 2016;95:e3393.
  • Saviano A, Iezzi R, Giuliante F, et al. Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28:1512–1519.
  • Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014;259:1195–1200.
  • Kim SS, Kang TW, Kim M, et al. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation. Clin Radiol. 2018;73:216.e1–216.e8.
  • Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: an updated review. Wjgpt. 2016;7:477–489.
  • Makino Y, Imai Y, Igura T, et al. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis. 2013;31:485–489.
  • Passera K, Selvaggi S, Scaramuzza D, et al. Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing. BMC Med Imaging. 2013;13:3.
  • Wang XL, Li K, Su ZZ, et al. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. Wjg. 2015;21:5345–5351.
  • Beigi P, Malenfant P, Rasoulian A, et al. Three-dimensional ultrasound-guided real-time midline epidural needle placement with epiguide: a prospective feasibility study. Ultrasound Med Biol. 2017;43:375–379.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
  • Medhat E, Abdel AA, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma. J Dig Dis. 2015;16:456–463.
  • Tamai T, Oshige A, Tabu K, et al. Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma. Oncol Lett. 2017;14:3199–3206.
  • Hansen C, Wieferich J, Ritter F, et al. Illustrative visualization of 3D planning models for augmented reality in liver surgery. Int J Cars. 2010;5:133–141.
  • Liu F, Liang P, Yu X, et al. A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. Int J Hyperthermia. 2013;29:671–677.
  • Lopresto V, Pinto R, Farina L, et al. Microwave thermal ablation: effects of tissue properties variations on predictive models for treatment planning. Med Eng Phys. 2017;46:63–70.
  • Zuo TY, Liu FY, Wang MQ, et al. Transcatheter arterial chemoembolization combined with simultaneous computed tomography-guided radiofrequency ablation for large hepatocellular carcinomas. Chin Med J. 2017;130:2666–2673.
  • Yan JY, Zhang JL, Wang MQ, et al. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Asia Pac J Clin Oncol. 2017.